StockData
Guardant Health, Inc. logo

Guardant Health, Inc. (GH) stock

GHNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$154.86+0.08 (+0.05%)

Close on Nov 12, 2026Market cap $20.78BP/E –Yield –

Guardant Health gross margin

Gross margin is gross profit as a percentage of revenue.

Guardant Health's gross margin for the twelve months ending Sep 30, 2026 was 65.2%. For fiscal 2025 it was 64.5%, against 60.8% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202564.5%+3.7
FY2024Dec 31, 202460.8%+1.0
FY2023Dec 31, 202359.7%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202665.4%+0.7
Q2 FY2026Jun 30, 202665.4%+0.4
Q1 FY2026Mar 31, 202665.2%+1.9
Q4 FY2025Dec 31, 202564.6%+3.1
Q3 FY2025Sep 30, 202564.7%+3.6
Q2 FY2025Jun 30, 202565.0%+5.9
Q1 FY2025Mar 31, 202563.3%+2.0
Q4 FY2024Dec 31, 202461.6%–
Q3 FY2024Sep 30, 202461.1%–
Q2 FY2024Jun 30, 202459.1%–
Q1 FY2024Mar 31, 202461.2%–

More Guardant Health figures

See a number that looks wrong?